2 completed, 2 unknown, 1 not yet recruiting. 5 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 2, Unknown 2, Not yet recruiting 1 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow Tms: new trials by email Literature Review of Tms trials Research Report on Tms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days Transcranial magnetic stimulation, Sham transcranial magnetic stimulation - PTSD | Phase 3 | Not yet recruiting | VA Office of Research and Development | 90 | 2026-11-16 | 2026-10-05 |
| Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis Transcranial Magnetic Stimulation, Amantadine Hydrochloride 100 mg (milligrams) Oral Capsule - Multiple Sclerosis, Fatigue | Phase 3 | Unknown | Hospital San Carlos, Madrid | 144 | 2022-11-28 | 2023-12-11 |
| Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet, Telmisartan 40Mg Oral Tablet, Atorvastatin 20 Mg Oral Tablet - COVID-19, COVID-19 Drug Treatment | Phase 2 / Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 294 | 2020-11-27 | 2024-12-27 |
| Maintenance rTMS for Treatment-resistant Depression (TRD): a One-year Double Blind Controlled Study Repetitive Transcranial Magnetic Stimulation - Major Depressive Disorder | Phase 2 / Phase 3 | Unknown | Centre hospitalier de Ville-Evrard, France | 40 | 2007-01-01 | 2015-03-09 |
| Magnetic Brain Stimulation for the Treatment of Adult Depression Prefrontal rTMS, Antidepressant Regimen, Sham Stimulation - Depression | Phase 2 / Phase 3 | Completed | Medical University of South Carolina | 190 | 2005-02-01 | 2018-12-28 |
Depression (2) · COVID-19 (1) · Depressive Disorder, Major (1) · Fatigue (1) · Multiple Sclerosis (1) · Stress Disorders, Post-Traumatic (1)
ANRS, Emerging Infectious Diseases (1) · Centre hospitalier de Ville-Evrard, France (1) · Hospital San Carlos, Madrid (1) · Medical University of South Carolina (1) · VA Office of Research and Development (1)
United States (2) · Côte d’Ivoire (1) · France (1) · Spain (1)
Jorge Matias-Guiu Guia, MD PhD (1) · Mark S. George, MD (1) · Michelle R Madore, PhD (1)
PMID 20439832, PMID 23769413, PMID 38176857, PMID 39443527
R01MH069887 (1)